In view of that, understanding the role of leptin in metabolic disorders is indeed complex, and due to the discrepancies in the findings of previous studies that suggest that leptin levels could be a consequence of the pathologies and not a prognostic marker, we performed a meta-analysis to investigate the role of leptin in individuals with diabetes or obesity. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.